We observed significant increases in levels of plasma IL-17A and IL-21 in PB and BM from newly diagnosed B-ALL patients compared with those from healthy donors (Fig. 2a and b). Here, IL17A is linked to precursor B-cell acute lymphoblastic leukemia.